Samsrita Labs Ltd.
BSE: SAMSRITA
Prev Close
23.09
Open Price
22.63
Volume
1,241
Today Low / High
22.63 / 22.63
52 WK Low / High
12.19 / 32.36
Range
21 - 24
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 22.63, reflecting a change of -0.46 (-1.9922%). The expected target range on the BSE is 21 - 24. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Samsrita Labs Ltd. Graph
Samsrita Labs Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Samsrita Labs Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 22.63, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 22.63 | 22.86 | 20.57 - 25.14 |
| 23.08 | 18.47 - 27.70 | ||
| 23.31 | 16.32 - 30.30 | ||
| Bearish Scenario | 22.63 | 22.40 | 20.16 - 24.64 |
| 22.18 | 17.74 - 26.61 | ||
| 21.95 | 15.37 - 28.54 |
Overview of Samsrita Labs Ltd.
ISIN
INE579N01018
Industry
Biotechnology
Vol.Avg
1,719
Market Cap
348,892,972
Last Dividend
0
Official Website
IPO Date
DCF Diff
25.24
DCF
-2
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | 0.00 Cr | -0.13 Cr | -0.26 Cr | -0.18 | -0.26 Cr | 0.0000 |
| 2024-03-31 | 0.00 Cr | 0.13 Cr | -0.13 Cr | 0.0000 | 0.00 Cr | 0.02 Cr | -0.15 Cr | -0.26 Cr | -0.18 | -0.25 Cr | 0.0000 |
| 2023-03-31 | 0.02 Cr | 0.15 Cr | 0.00 Cr | 0.0556 | 0.00 Cr | 0.11 Cr | -0.25 Cr | -0.71 Cr | -0.48 | -0.70 Cr | -32.7407 |
| 2022-03-31 | 0.02 Cr | 0.27 Cr | -0.13 Cr | -5.7985 | 0.00 Cr | 0.02 Cr | -0.40 Cr | 1.49 Cr | 1.00 | -0.40 Cr | 66.2376 |
| 2021-03-31 | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.5909 | 0.00 Cr | 0.04 Cr | -0.91 Cr | -0.77 Cr | -0.52 | -0.91 Cr | -59.3337 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 Cr | 15.68 Cr | 3.60 Cr | 12.0837 Cr | 2.43 Cr | 2.42 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 4.87 Cr | 3.4833 Cr |
| 2024-03-31 | 0.00 Cr | 15.55 Cr | 3.29 Cr | 12.2578 Cr | 2.20 Cr | 2.20 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 4.79 Cr | 3.1929 Cr |
| 2023-03-31 | 0.01 Cr | 15.56 Cr | 3.04 Cr | 12.5201 Cr | 2.08 Cr | 2.07 Cr | 0.00 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 4.80 Cr | 2.9571 Cr |
| 2022-03-31 | 0.01 Cr | 17.13 Cr | 3.90 Cr | 13.2272 Cr | 2.74 Cr | 2.73 Cr | -0.04 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 4.80 Cr | 3.8306 Cr |
| 2021-03-31 | 0.00 Cr | 16.58 Cr | 5.42 Cr | 11.1519 Cr | 2.34 Cr | 2.34 Cr | 0.13 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 4.22 Cr | 5.3793 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.2253 Cr | 0.0000 Cr | 0.2234 Cr | -0.2253 Cr | -0.0019 Cr | 0.0024 Cr | 0.0000 Cr | -0.2595 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | -0.1286 Cr | 0.0000 Cr | 0.1277 Cr | -0.1286 Cr | -0.0009 Cr | 0.0043 Cr | 0.1286 Cr | -0.2622 Cr | 0.1277 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | 0.6612 Cr | 0.0000 Cr | -0.6652 Cr | 0.6612 Cr | -0.0040 Cr | 0.0053 Cr | 0.0000 Cr | -0.7057 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | -0.3950 Cr | 0.0000 Cr | 0.4002 Cr | -0.3950 Cr | 0.0051 Cr | 0.0092 Cr | 0.0000 Cr | 1.4873 Cr | 0.4002 Cr | 0.0000 Cr | 0.1292 Cr |
| 2021-03-31 | -0.3411 Cr | -0.2273 Cr | 0.5490 Cr | -0.5684 Cr | -0.0253 Cr | 0.0041 Cr | -0.2273 Cr | -0.7697 Cr | 0.5490 Cr | 0.0000 Cr | 0.0019 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | -0.28 Cr | -0.28 Cr | -0.19 | -0.28 Cr | 0.0000 |
| 2025-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | 0.00 Cr | -0.09 Cr | -0.06 | 0.00 Cr | 0.0000 |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | -0.03 Cr | -0.04 Cr | -0.03 | -0.04 Cr | 0.0000 |
| 2024-09-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | -0.03 Cr | -0.04 Cr | -0.03 | -0.04 Cr | 0.0000 |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | -0.03 Cr | -0.09 Cr | -0.06 | -0.09 Cr | 0.0000 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 0.00 Cr | 5.54 Cr | 0.01 Cr | 15.68 Cr | 3.60 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -12.21 Cr |
| 2024-09-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 0.00 Cr | 5.51 Cr | 0.01 Cr | 15.65 Cr | 3.43 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -12.34 Cr |
| 2024-03-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 0.00 Cr | 5.50 Cr | 0.01 Cr | 15.55 Cr | 3.29 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | -0.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | -0.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹360.25 | ₹481,639,840,000.00 | ₹2,377,375.00 |
| Syngene International Limited | SYNGENE | ₹659.15 | ₹264,559,669,880.00 | ₹531,474.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹192.13 | ₹255,388,456,666.00 | ₹2,518,788.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,633.60 | ₹170,901,024,320.00 | ₹64,779.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹791.75 | ₹137,341,246,285.00 | ₹618,017.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹698.20 | ₹111,209,994,200.00 | ₹170,522.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹656.00 | ₹52,796,716,800.00 | ₹99,003.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹254.90 | ₹39,963,986,700.00 | ₹44,875.00 |
| Zota Health Care Limited | ZOTA | ₹1,339.30 | ₹39,460,465,550.00 | ₹193,378.00 |
| Panacea Biotec Limited | PANACEABIO | ₹430.65 | ₹26,377,613,955.00 | ₹150,143.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born: 1959
Gender: male
Year Born: 1977
FAQs about Samsrita Labs Ltd.
The CEO is Kalidindi Krishnam Raju.
The current price is ₹23.56.
The range is ₹12.19-32.36.
The market capitalization is ₹34.89 crores.
The P/E ratio is -76.41.
The company operates in the Healthcare sector.
Overview of Samsrita Labs Ltd. (ISIN: INE579N01018) is a leading Biotechnology in India. With a market capitalization of ₹34.89 crores and an average daily volume of 1,719 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.